By Jeff Overley ( September 24, 2018, 7:05 PM EDT) -- Amarin Corp. PLC on Monday reported eye-popping cardiovascular benefits from its omega-3 drug Vascepa, lending credence to off-label uses the company was allowed to promote under a historic court ruling against the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.